Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody

Overview of attention for article published in Cancer Immunology, Immunotherapy, August 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#18 of 3,024)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 7 news stories from 7 outlets.

By Douglas McBride : Discussion Many investors that look at Inovio see a 2020 market opportunity for Inovio's flagship product (V…

Discussion Many investors that look at Inovio see a 2020 market opportunity for Inovio’s flagship product (VGX-3100) for…

Aug. 17 (UPI) — Researchers at The Wistar Institute have created a new immunotherapy technology to treat prostate cancer using…

Aug. 17 (UPI) -- Researchers at The Wistar Institute have created a new immunotherapy technology to treat prostate cancer using…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 3 additional news stories.